- (0:50) - Why Should Investors Consider Investing In The Cannabis Industry?
- (7:00) - Tim Seymour’s Background In The Cannabis Market
- (14:15) - What Is The Growth Potential and What Will Drive It?
- (20:45) - Medical vs Recreational: What Stands To Benefit The Most?
- (27:50) - Can We Expect Federal Legal Changes Anytime Soon?
- (33:05) - Amplify Seymour Cannabis ETF: CNBS
- (44:40) - Breaking Down CNBS Top Holdings
- (49:50) - Risks and Areas To Be Cautious Of Within The Cannabis Industry
- (55:00) - How Can Investors Benefit From Thematic Investing?
In this episode of ETF Spotlight, I speak with Tim Seymour, founder & CIO of Seymour Asset Management and co-host of CNBC's Fast Money, and Christian Magoon, founder & CEO of Amplify ETFs.
We discuss cannabis investing and the Amplify Seymour Cannabis ETF CNBS, which is actively managed by Tim.
We start with the investment case for cannabis--why investors should consider marijuana stocks and ETFs. Per Amplify, global legal cannabis sales have risen approximately 30% per year recently, with 2019 sales expected to grow 39% from 2018.
Tim is an early stage cannabis investor and also serves as a board member for several private cannabis companies. What drew him to the cannabis industry?
Recreational marijuana use is now legal in 11 states and Washington D.C. and medical marijuana use is legal in 33 states, but it remains illegal at the federal level. We discuss the current regulatory landscape, rising support for legalizing cannabis and recent legislative developments.
CNBS invests in marijuana companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem. Its top holdings include Canopy Growth CGC Aurora Cannabis ACB, GW Pharmaceuticals GWPH MediPharm Labs, Organigram Holdings OGI Village Farms International VFF and Canaccord Genuity.
Tim talks about some of his favorite cannabis stocks.
There are four more pot ETFs available to investors now--the ETFMG Alternative Harvest ETF MJ, the AdvisorShares Pure Cannabis ETF YOLO, The Cannabis ETF THCX and the Cambria Cannabis ETF TOKE. How is CNBS different from other pot ETFs?
Are there any pot stocks investors should stay away from? CannTrust Holdings CTST has lost more than 50% of its value since it disclosed a serious regulatory breach on July 8. What else do investors need to know?
Amplify has a number of ETFs focused on disruptive themes, like the Amplify Online Retail ETF IBUY. We talk about the role of thematic ETFs in investors’ portfolios.
Please visit AmplifyETF.com to learn more about CNBS and other Amplify ETFs.
Make sure to be on the lookout for the next edition of ETF Spotlight! If you have any comments or questions, please email email@example.com.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amplify Online Retail ETF (IBUY): ETF Research Reports
GW Pharmaceuticals PLC (GWPH) : Free Stock Analysis Report
Canopy Growth Corporation (CGC) : Free Stock Analysis Report
Village Farms International, Inc. (VFF) : Free Stock Analysis Report
Aurora Cannabis Inc. (ACB) : Free Stock Analysis Report
Organigram Holdings Inc. (OGI) : Free Stock Analysis Report
CannTrust Holdings Inc. (CTST) : Free Stock Analysis Report
AdvisorShares Pure Cannabis ETF (YOLO): ETF Research Reports
ETFMG Alternative Harvest ETF (MJ): ETF Research Reports
The Cannabis ETF (THCX): ETF Research Reports
AMP-SYMR CANNBS (CNBS): ETF Research Reports
CAMBRIA-CANNBIS (TOKE): ETF Research Reports
To read this article on Zacks.com click here.
Zacks Investment Research